Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in mice - Concepedia

Concepedia

Publication | Open Access

Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in mice

DOI Full Paper Access

101

Citations

27

References

2007

Year

Renate Paddenberg, Philipp Stieger, Anna-Laura von Lilien, Petra Faulhammer, Anna Goldenberg, Harald Tillmanns, Wolfgang Kummer, Ruediger C. Braun‐Dullaeus

Respiratory Research

Abstract

Therapy with rapamycin may represent a new strategy for the treatment of pulmonary hypertension.

References

	Year	Citations
Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery Jeffrey W. Moses, Martin B. Leon, Jeffrey J. Popma, New England Journal of Medicine	2003	4.2K
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization Marie‐Claude Morice, Patrick W. Serruys, J. Eduardo Sousa, New England Journal of Medicine	2002	4K
Reversal of experimental pulmonary hypertension by PDGF inhibition Ralph T. Schermuly Journal of Clinical Investigation HypertensionRv PressureLung InflammationPulmonary HypertensionMolecular Pharmacology	2005	1K
A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin John J. Siekierka, Shirley H.Y. Hung, Martin Poe, Nature InflammationProtein FunctionSignal TransductionProtein ExpressionBiochemistry	1989	1K
Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary Revascularization Stephan Windecker, Andréa Remondino, Franz R. Eberli, New England Journal of Medicine	2005	591
Rapamycin inhibits vascular smooth muscle cell migration. Michael Poon, Steven O. Marx, Richard L. Gallo, Journal of Clinical Investigation AngiogenesisMedicineVascular PharmacologyMacrolide Antibiotic RapamycinCell Migration	1996	510
Sildenafil Inhibits Hypoxia-Induced Pulmonary Hypertension Lan Zhao, Nicola A. Mason, Nicholas W. Morrell, Circulation	2001	484
Imatinib for the Treatment of Pulmonary Arterial Hypertension Hossein Ardeschir Ghofrani, Werner Seeger, Friedrich Grimminger New England Journal of Medicine HypertensionAntifibrotic TherapyHeart FailureOral BosentanPulmonary Hypertension	2005	479
Rapamycin Attenuates Load-Induced Cardiac Hypertrophy in Mice Tetsuo Shioi, Julie R. McMullen, Oleg Tarnavski, Circulation	2003	460
Sirolimus in De Novo Heart Transplant Recipients Reduces Acute Rejection and Prevents Coronary Artery Disease at 2 Years Anne Keogh, Peter Ruygrok, Phillip Spratt, Circulation	2004	455

Page 1